Physician profile
Sanjay Menon
NPI 1588855159
$8,067.90
in general payments reported to CMS, 2019-2025
11 companies · $1,391 in 2025
The $1,391 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,057 · 2020: $1,749 · 2021: $949 · 2022: $248 · 2023: $400 · 2024: $1,273 · 2025: $1,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,668 · Travel and Lodging: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,667.85 |
| Travel and Lodging | $1,396.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,627.98 | 2019-2025 | Mako, Insignia, Motionsense Digital Goniometer |
| Arthrex, INC. | $2,289.54 | 2019-2025 | |
| Depuy Synthes Sales INC. | $1,337.24 | 2020-2025 | |
| Smith+Nephew, INC. | $759.02 | 2019-2024 | Legion Revision, Journey II, Real Intelligence |
| Mvp Orthopedics INC | $447.40 | 2020 | |
| Zimmer Biomet Holdings, INC. | $334.78 | 2019-2021 | |
| Medical Device Business Services, INC. | $149.05 | 2020-2021 | |
| Coastal Medical Technologies LLC | $66.99 | 2025 | |
| Kerecis Limited | $23.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Janssen Pharmaceuticals, INC | $19.15 | 2023 | Xarelto |
| Molnlycke Health Care US, LLC | $12.85 | 2024 | Mepilex Border Post-Op Ag, Avance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Menon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.